SCHEMBL7684826

SCHEMBL7684826

COC1(C(=O)O)CC=CC=C1c1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 7/20 0.34
CYP3A4 P08684 6/20 0.34
HSD17B10 Q99714 6/20 0.34
ALDH1A1 P00352 5/20 0.34
CYP1A2 P05177 3/20 0.34
MAPK1 P28482 6/20 0.33
TP53 P04637 2/20 0.33
CYP2D6 P10635 2/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
HPGD P15428 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
CYP2C19 P33261 5/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CYP2C9 P11712 3/20 0.32
HIF1A Q16665 2/20 0.32
ALOX15 P16050 1/20 0.32
ALOX12 P18054 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9591212 0.88 MCL1 (0.33) CYP3A4ALDH1A1SMN1; SMN2CYP2C19KMT2A
SCHEMBL27874345 0.80 HK2 (0.30) HK2
SCHEMBL28172298 0.76 MEN1 (0.39) USP2CYP3A4HSD17B10ALDH1A1CYP1A2
SCHEMBL6269405 0.76 KDM4E (0.30) HSD17B10
SCHEMBL505430 0.76 AKR1C1 (0.35) SMN1; SMN2MEN1KMT2AAKR1C1
SCHEMBL8585802 0.75 GAA (0.32) HSD17B10ALDH1A1SMN1; SMN2HK2
SCHEMBL27914188 0.75 ALDH1A1 (0.39) ALDH1A1CYP1A2MAPK1CYP2D6CYP2C19
SCHEMBL28048789 0.75 GAA (0.33) USP2HSD17B10ALDH1A1CYP1A2MAPK1
SCHEMBL28379914 0.75 SLC6A4 (0.34) USP2CYP3A4HSD17B10ALDH1A1CYP1A2
SCHEMBL28945459 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025047357-A1 ELECTROLYTIC CAPACITOR AND ADDITIVE FOR LIQUID COMPONENT OF ELECTROLYTIC CAPACITOR パナソニックIPマネジメント株式会社 2025-03-06 WO disclosed
US-20020040060-A1 Biphenyl derivatives BOS MICHAEL (CA) 2002-04-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020040060-A1 Biphenyl derivatives NR1H4, NR1H2, NR1H3 USP2 2149/4885CYP3A4 532/4885HSD17B10 944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.